Search Results - "D'Aquila, T"

Very High HIV Incidence and Associated Risk Factors in a Longitudinal Cohort Study of Diverse Adolescent and Young Adult Men Who Have Sex with Men and Transgender Women by Mustanski, Brian, Ryan, Daniel T., Newcomb, Michael E., D’Aquila, Richard T., Matson, Margaret

“…To report HIV incidence and associated factors among young men who have sex with men (YMSM) and transgender women (TW). Data were collected February 2015 to…”
Get full text

Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure by Paredes, Roger, Lalama, Christina M., Ribaudo, Heather J., Schackman, Bruce R., Shikuma, Cecilia, Giguel, Francoise, Meyer, William A., Johnson, Victoria A., Fiscus, Susan A., D'Aquila, Richard T., Gulick, Roy M., Kuritzkes, Daniel R.

“…Background. The clinical relevance of detecting minority drug-resistant human immunodeficiency virus type 1 (HIV-1) variants is uncertain. Methods. To…”
Get full text

PrEP Use and Sexually Transmitted Infections Are Not Associated Longitudinally in a Cohort Study of Young Men Who Have Sex with Men and Transgender Women in Chicago by Morgan, Ethan, Dyar, Christina, Newcomb, Michael E., D’Aquila, Richard T., Mustanski, Brian

“…Our goal was to understand whether PrEP users are at increased risk for STIs, a key target in prevention efforts aimed at disrupting the spread of STIs and…”
Get full text

Transgender Women’s Concerns and Preferences on Potential Future Long-Acting Biomedical HIV Prevention Strategies: The Case of Injections and Implanted Medication Delivery Devices (IMDDs) by Rael, Christine Tagliaferri, Martinez, Michelle, Giguere, Rebecca, Bockting, Walter, MacCrate, Caitlin, Mellman, Will, Valente, Pablo, Greene, George J., Sherman, Susan G., Footer, Katherine H. A., D’Aquila, Richard T., Carballo-Diéguez, Alex, Hope, Thomas J.

“…There are several long-acting biomedical HIV prevention products in the development pipeline, including injections and implanted medication delivery devices…”
Get full text

Discordance of Self-report and Laboratory Measures of HIV Viral Load Among Young Men Who Have Sex with Men and Transgender Women in Chicago: Implications for Epidemiology, Care, and Prevention by Mustanski, Brian, Ryan, Daniel T., Remble, Thomas A., D’Aquila, Richard T., Newcomb, Michael E., Morgan, Ethan

“…Suppressing HIV viral load through daily antiretroviral therapy (ART) substantially reduces the risk of HIV transmission, however, the potential population…”
Get full text

Does body mass index explain the apparent anti-inflammatory effects of cannabis use? Results From a cohort study of sexual and gender minority youth by Schrock, Joshua M., McDade, Thomas W., D’Aquila, Richard T., Mustanski, Brian

“…Cannabis use has been linked to lower systemic inflammation, but the pathways connecting cannabis use and systemic inflammation are unclear. Here we…”
Get full text

Traumatic events and mental health: The amplifying effects of pre-trauma systemic inflammation by Schrock, Joshua M., McDade, Thomas W., Carrico, Adam W., D'Aquila, Richard T., Mustanski, Brian

“…•Experiments have shown that inflammation can amplify the aversiveness of threats.•We hypothesized that inflammation amplifies the impact of trauma on mental…”
Get full text

Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals by Demonbreun, Alexis R., Sancilio, Amelia, Velez, Matt P., Ryan, Daniel T., Saber, Rana, Vaught, Lauren A., Reiser, Nina L., Hsieh, Ryan R., D'Aquila, Richard T., Mustanski, Brian, McNally, Elizabeth M., McDade, Thomas W.

“…Recent reports have suggested that among individuals previously infected with SARS-CoV-2, a single mRNA vaccine dose is sufficient to elicit high levels of…”
Get full text

Phospholipase D1 Couples CD4+ T Cell Activation to c-Myc-Dependent Deoxyribonucleotide Pool Expansion and HIV-1 Replication by Taylor, Harry E, Simmons, Jr, Glenn E, Mathews, Thomas P, Khatua, Atanu K, Popik, Waldemar, Lindsley, Craig W, D'Aquila, Richard T, Brown, H Alex

“…Quiescent CD4+ T cells restrict human immunodeficiency virus type 1 (HIV-1) infection at early steps of virus replication. Low levels of both…”
Get full text

Immune control of HIV-1 after early treatment of acute infection by Walker, Bruce D, Rosenberg, Eric S, Altfeld, Marcus, Poon, Samuel H, Phillips, Mary N, Wilkes, Barbara M, Eldridge, Robert L, Robbins, Gregory K, D'Aquila, Richard T, Goulder, Philip J. R

“…Virus-specific T-helper cells are considered critical for the control of chronic viral infections. Successful treatment of acute HIV-1 infection leads to…”
Get full text

Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society-USA Panel by Hirsch, Martin S., Brun-Vézinet, Françoise, Clotet, Bonaventura, Conway, Brian, Kuritzkes, Daniel R., D'Aquila, Richard T., Demeter, Lisa M., Hammer, Scott M., Johnson, Victoria A., Loveday, Clive, Mellors, John W., Jacobsen, Donna M., Richman, Douglas D.

“…New information about the benefits and limitations of testing for resistance to human immunodeficiency virus (HIV) type 1 (HIV-1) drugs has emerged. The…”
Get full text

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation by Donahue, John P, Vetter, Michael L, Mukhtar, Nizar A, D'Aquila, Richard T

“…Abstract The HIV-1 virion infectivity factor (Vif) is required during viral replication to inactivate the host cell anti-viral factor, APOBEC3G (A3G). Vif…”
Get full text

Preexisting Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz-Based Regimen in Treatment-Naive HIV-1–Infected Subjects by Kuritzkes, Daniel R., Lalama, Christina M., Ribaudo, Heather J., Marcial, Michelle, Meyer, William A., Shikuma, Cecilia, Johnson, Victoria A., Fiscus, Susan A., D'Aquila, Richard T., Schackman, Bruce R., Acosta, Edward P., Gulick, Roy M.

“…A case-cohort study was used to determine the effect of baseline nonnucleoside reverse-transcriptase inhibitor (NNRTI) resistance, as assessed by viral…”
Get full text

APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo by Kourteva, Yordanka, De Pasquale, MariaPia, Allos, Tara, McMunn, Chara, D'Aquila, Richard T

“…Abstract APOBEC3G (A3G) and APOBEC3F (A3F) reduce Vif-negative HIV-1 provirus formation and cause disabling provirus G-to-A hypermutation in vitro . However,…”
Get full text

Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo by De Pasquale, Mariapia, Kourteva, Yordanka, Allos, Tara, D'Aquila, Richard T

“…Immunodeficiency does not progress for prolonged periods in some HLA B57- and/or B27-positive subjects with human immunodeficiency virus type 1 (HIV)…”
Get full text

Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1 by Martinez-Picado, J, Savara, A V, Sutton, L, D'Aquila, R T

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Dynamics of Total, Linear Nonintegrated, and Integrated HIV-1 DNA In Vivo and In Vitro by Koelsch, Kersten K., Liu, Lin, Haubrich, Richard, May, Susanne, Havlir, Diane, Günthard, Huldrych F., Ignacio, Caroline C., Campos-Soto, Paula, Little, Susan J., Shafer, Robert, Robbins, Gregory K., D'Aquila, Richard T., Kawano, Yuji, Young, Karen, Dao, Phillip, Spina, Celsa A., Richman, Douglas D., Wong, Joseph K.

“…Background. In patients infected with human immunodeficiency virus type 1 (HIV-1), HIV-1 DNA persists during highly active antiretroviral treatment, reflecting…”
Get full text

Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study by Haas, David W., Smeaton, Laura M., Shafer, Robert W., Robbins, Gregory K., Morse, Gene D., Labbé, Line, Wilkinson, Grant R., Clifford, David B., D’Aquila, Richard T., De Gruttola, Victor, Pollard, Richard B., Merigan, Thomas C., Hirsch, Martin S., George, Alfred L., Donahue, John P., Kim, Richard B.

“…BackgroundEfavirenz and nelfinavir are metabolized by cytochrome P-450 (CYP) 2B6 and CYP2C19, respectively, with some involvement by CYP3A. Nelfinavir is a…”
Get full text

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: Recommendations of an International AIDS Society–USA Panel by Hirsch, Martin S, Brun-Vézinet, Françoise, D'Aquila, Richard T, Hammer, Scott M, Johnson, Victoria A, Kuritzkes, Daniel R, Loveday, Clive, Mellors, John W, Clotet, Bonaventura, Conway, Brian, Demeter, Lisa M, Vella, Stefano, Jacobsen, Donna M, Richman, Douglas D

“…OBJECTIVE Assays for drug resistance testing in human immunodeficiency virus type 1 (HIV-1) infection are now available and clinical studies suggest that viral…”
Get full text

Immunogenetics of CD4 Lymphocyte Count Recovery during Antiretroviral Therapy: An AIDS Clinical Trials Group Study by Haas, David W., Geraghty, Daniel E., Andersen, Janet, Mar, Jessica, Motsinger, Alison A., D’Aquila, Richard T., Unutmaz, Derya, Benson, Constance A., Ritchie, Marylyn D., Landay, Alan

“…During antiretroviral therapy, CD4 lymphocyte count increases are modest in some patients despite virologic control. We explored whether polymorphisms in genes…”
Get full text